Perspectives and progress in development of breast cancer chemopreventive drugs.

Kelloff, G J; Boone, C W; Crowell, J A; Nayfield, S G; Hawk, E T; Steele, V E; Lubet, R A; Sigman, C C

Kelloff, G J; Boone, C W; Crowell, J A; Nayfield, S G; Hawk, E T; Steele, V E; Lubet, R A; Sigman, C C.

Affiliation

Kelloff GJ; Division of Cancer Prevention and Control, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Prog Clin Biol Res ; 396: 159-83, 1997.

Article in En | MEDLINE | ID: mdl-9108597

Subject(s)

Antineoplastic Agents/therapeutic use; Breast Neoplasms/prevention & control; Biomarkers, Tumor; Dehydroepiandrosterone/therapeutic use; Estrogen Antagonists/therapeutic use; Female; Fenretinide/therapeutic use; Humans; Risk Factors; Tamoxifen/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Prog Clin Biol Res Year: 1997 Document type: Article

Search on Google

XML

PubMed Links